Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.

A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, ...

智通财经获悉，远程医疗平台公司Hims & Hers Health(HIMS.US)首席执行官Andrew Dudum表示，该公司正准备在2025年推出诺和诺德(NVO.US)的旧版GLP-1减肥疗法liraglutide的非专利版本。liraglutide分别以Victoza和Saxenda的形式销售，用于治疗糖尿病和肥胖症。在2024年上半年，liraglutide为这家丹麦制药商带来 ...

FRIDAY, Nov. 22, 2024 (HealthDay News) -- Semaglutide and liraglutide are associated with a reduced risk for hospitalization ...

Sometimes hyped as miracle drugs, even whispered about as elixirs, semaglutide and brand-name variants such as Ozempic and ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year.

Compared with standard AUD medications, the use of semaglutide and liraglutide was linked to a lower risk for alcohol use ...